APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peripheral Vasodilator Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Peripheral Vasodilator Drugs Industry Growth and Trends Forecast to 2032

23 December 2025117 pages

Choose your research edition.

Industry ResearchPeripheral Vasodilator Drugs Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Peripheral Vasodilator Drugs Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Peripheral Vasodilator Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peripheral Vasodilator Drugs Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Peripheral Vasodilator Drugs Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Peripheral Vasodilator Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peripheral Vasodilator Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peripheral Vasodilator Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peripheral Vasodilator Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peripheral Vasodilator Drugs include Endovastec, Aotecar Medical-B, Tibet Cheezheng Tibetan Medicine Co., Ltd, Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Pfizer, Inc., GSK plc and Bayer AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peripheral Vasodilator Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peripheral Vasodilator Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peripheral Vasodilator Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peripheral Vasodilator Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Peripheral Vasodilator Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peripheral Vasodilator Drugs Market by Company

Endovastec

Aotecar Medical-B

Tibet Cheezheng Tibetan Medicine Co., Ltd

Teva Pharmaceutical Industries Ltd.

Sanofi

Novartis AG

Pfizer, Inc.

GSK plc

Bayer AG

Bat Medical

AstraZeneca

Viatris, Inc.

Sun Pharmaceutical Industries Ltd.

Merck & Co., Inc.

Lupin

Bristol-Myers Squibb Company

Boehringer Ingelheim International GmbH

Abbott Laboratories

Peripheral Vasodilator Drugs Segment by Type

Alpha-adrenergic Blockers

Calcium Channel Blockers

Potassium Channel Activators

Others

Peripheral Vasodilator Drugs Segment by Application

Hospital

Retail Pharmacies

Others

Peripheral Vasodilator Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peripheral Vasodilator Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peripheral Vasodilator Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peripheral Vasodilator Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peripheral Vasodilator Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Peripheral Vasodilator Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Alpha-adrenergic Blockers Table 2. Major Company of Calcium Channel Blockers Table 3. Major Company of Potassium Channel Activators Table 4. Major Company of Others Table 5. Global Peripheral Vasodilator Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 7. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Peripheral Vasodilator Drugs Price by Type (2021-2026) & (USD/unit) Table 11. Global Peripheral Vasodilator Drugs Sales by Type (2027-2032) & (k units) Table 12. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Peripheral Vasodilator Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Peripheral Vasodilator Drugs Price by Type (2027-2032) & (USD/unit) Table 16. North America Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 17. North America Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 19. Europe Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 23. Latin America Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Peripheral Vasodilator Drugs Industry Trends Table 27. Peripheral Vasodilator Drugs Industry Drivers Table 28. Peripheral Vasodilator Drugs Industry Opportunities and Challenges Table 29. Peripheral Vasodilator Drugs Industry Restraints Table 30. Global Peripheral Vasodilator Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Peripheral Vasodilator Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Peripheral Vasodilator Drugs Sales by Company (2021-2026) & (k units) Table 33. Global Peripheral Vasodilator Drugs Sales Share by Company (2021-2026) Table 34. Global Peripheral Vasodilator Drugs Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Peripheral Vasodilator Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Peripheral Vasodilator Drugs Major Company Production Sites and Headquarters Table 37. Global Peripheral Vasodilator Drugs Company, Product Type & Application Table 38. Global Peripheral Vasodilator Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Peripheral Vasodilator Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Peripheral Vasodilator Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Peripheral Vasodilator Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Peripheral Vasodilator Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Peripheral Vasodilator Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Peripheral Vasodilator Drugs Sales by Region (2027-2032) & (k units) Table 48. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Peripheral Vasodilator Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Peripheral Vasodilator Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Peripheral Vasodilator Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Peripheral Vasodilator Drugs Price by Application (2021-2026) & (USD/unit) Table 58. Global Peripheral Vasodilator Drugs Sales by Application (2027-2032) & (k units) Table 59. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Peripheral Vasodilator Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Peripheral Vasodilator Drugs Price by Application (2027-2032) & (USD/unit) Table 63. North America Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 64. North America Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 66. Europe Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 70. Latin America Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Endovastec Company Information Table 74. Endovastec Business Overview Table 75. Endovastec Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Endovastec Peripheral Vasodilator Drugs Product Portfolio Table 77. Endovastec Recent Development Table 78. Aotecar Medical-B Company Information Table 79. Aotecar Medical-B Business Overview Table 80. Aotecar Medical-B Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Aotecar Medical-B Peripheral Vasodilator Drugs Product Portfolio Table 82. Aotecar Medical-B Recent Development Table 83. Tibet Cheezheng Tibetan Medicine Co., Ltd Company Information Table 84. Tibet Cheezheng Tibetan Medicine Co., Ltd Business Overview Table 85. Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Product Portfolio Table 87. Tibet Cheezheng Tibetan Medicine Co., Ltd Recent Development Table 88. Teva Pharmaceutical Industries Ltd. Company Information Table 89. Teva Pharmaceutical Industries Ltd. Business Overview Table 90. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Portfolio Table 92. Teva Pharmaceutical Industries Ltd. Recent Development Table 93. Sanofi Company Information Table 94. Sanofi Business Overview Table 95. Sanofi Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Sanofi Peripheral Vasodilator Drugs Product Portfolio Table 97. Sanofi Recent Development Table 98. Novartis AG Company Information Table 99. Novartis AG Business Overview Table 100. Novartis AG Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Novartis AG Peripheral Vasodilator Drugs Product Portfolio Table 102. Novartis AG Recent Development Table 103. Pfizer, Inc. Company Information Table 104. Pfizer, Inc. Business Overview Table 105. Pfizer, Inc. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Pfizer, Inc. Peripheral Vasodilator Drugs Product Portfolio Table 107. Pfizer, Inc. Recent Development Table 108. GSK plc Company Information Table 109. GSK plc Business Overview Table 110. GSK plc Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. GSK plc Peripheral Vasodilator Drugs Product Portfolio Table 112. GSK plc Recent Development Table 113. Bayer AG Company Information Table 114. Bayer AG Business Overview Table 115. Bayer AG Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Bayer AG Peripheral Vasodilator Drugs Product Portfolio Table 117. Bayer AG Recent Development Table 118. Bat Medical Company Information Table 119. Bat Medical Business Overview Table 120. Bat Medical Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Bat Medical Peripheral Vasodilator Drugs Product Portfolio Table 122. Bat Medical Recent Development Table 123. AstraZeneca Company Information Table 124. AstraZeneca Business Overview Table 125. AstraZeneca Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. AstraZeneca Peripheral Vasodilator Drugs Product Portfolio Table 127. AstraZeneca Recent Development Table 128. Viatris, Inc. Company Information Table 129. Viatris, Inc. Business Overview Table 130. Viatris, Inc. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Viatris, Inc. Peripheral Vasodilator Drugs Product Portfolio Table 132. Viatris, Inc. Recent Development Table 133. Sun Pharmaceutical Industries Ltd. Company Information Table 134. Sun Pharmaceutical Industries Ltd. Business Overview Table 135. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Portfolio Table 137. Sun Pharmaceutical Industries Ltd. Recent Development Table 138. Merck & Co., Inc. Company Information Table 139. Merck & Co., Inc. Business Overview Table 140. Merck & Co., Inc. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Merck & Co., Inc. Peripheral Vasodilator Drugs Product Portfolio Table 142. Merck & Co., Inc. Recent Development Table 143. Lupin Company Information Table 144. Lupin Business Overview Table 145. Lupin Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Lupin Peripheral Vasodilator Drugs Product Portfolio Table 147. Lupin Recent Development Table 148. Bristol-Myers Squibb Company Company Information Table 149. Bristol-Myers Squibb Company Business Overview Table 150. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product Portfolio Table 152. Bristol-Myers Squibb Company Recent Development Table 153. Boehringer Ingelheim International GmbH Company Information Table 154. Boehringer Ingelheim International GmbH Business Overview Table 155. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product Portfolio Table 157. Boehringer Ingelheim International GmbH Recent Development Table 158. Abbott Laboratories Company Information Table 159. Abbott Laboratories Business Overview Table 160. Abbott Laboratories Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Abbott Laboratories Peripheral Vasodilator Drugs Product Portfolio Table 162. Abbott Laboratories Recent Development Table 163. North America Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. North America Peripheral Vasodilator Drugs Sales by Country (2021-2026) & (k units) Table 165. North America Peripheral Vasodilator Drugs Sales Market Share by Country (2021-2026) Table 166. North America Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032) & (k units) Table 167. North America Peripheral Vasodilator Drugs Sales Market Share Forecast by Country (2027-2032) Table 168. North America Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. North America Peripheral Vasodilator Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. North America Peripheral Vasodilator Drugs Market Share by Country (2021-2026) Table 171. North America Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. North America Peripheral Vasodilator Drugs Market Share Forecast by Country (2027-2032) Table 173. Europe Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 174. Europe Peripheral Vasodilator Drugs Sales by Country (2021-2026) & (k units) Table 175. Europe Peripheral Vasodilator Drugs Sales Market Share by Country (2021-2026) Table 176. Europe Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032) & (k units) Table 177. Europe Peripheral Vasodilator Drugs Sales Market Share Forecast by Country (2027-2032) Table 178. Europe Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe Peripheral Vasodilator Drugs Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe Peripheral Vasodilator Drugs Market Share by Country (2021-2026) Table 181. Europe Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe Peripheral Vasodilator Drugs Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Peripheral Vasodilator Drugs Sales by Country (2021-2026) & (k units) Table 185. Asia-Pacific Peripheral Vasodilator Drugs Sales Market Share by Country (2021-2026) Table 186. Asia-Pacific Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032) & (k units) Table 187. Asia-Pacific Peripheral Vasodilator Drugs Sales Market Share Forecast by Country (2027-2032) Table 188. Asia-Pacific Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Asia-Pacific Peripheral Vasodilator Drugs Market Size by Country (2021-2026) & (US$ Million) Table 190. Asia-Pacific Peripheral Vasodilator Drugs Market Share by Country (2021-2026) Table 191. Asia-Pacific Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Asia-Pacific Peripheral Vasodilator Drugs Market Share Forecast by Country (2027-2032) Table 193. Latin America Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 194. Latin America Peripheral Vasodilator Drugs Sales by Country (2021-2026) & (k units) Table 195. Latin America Peripheral Vasodilator Drugs Sales Market Share by Country (2021-2026) Table 196. Latin America Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032) & (k units) Table 197. Latin America Peripheral Vasodilator Drugs Sales Market Share Forecast by Country (2027-2032) Table 198. Latin America Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Latin America Peripheral Vasodilator Drugs Market Size by Country (2021-2026) & (US$ Million) Table 200. Latin America Peripheral Vasodilator Drugs Market Share by Country (2021-2026) Table 201. Latin America Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Latin America Peripheral Vasodilator Drugs Market Share Forecast by Country (2027-2032) Table 203. Middle East and Africa Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 204. Middle East and Africa Peripheral Vasodilator Drugs Sales by Country (2021-2026) & (k units) Table 205. Middle East and Africa Peripheral Vasodilator Drugs Sales Market Share by Country (2021-2026) Table 206. Middle East and Africa Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032) & (k units) Table 207. Middle East and Africa Peripheral Vasodilator Drugs Sales Market Share Forecast by Country (2027-2032) Table 208. Middle East and Africa Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Middle East and Africa Peripheral Vasodilator Drugs Market Size by Country (2021-2026) & (US$ Million) Table 210. Middle East and Africa Peripheral Vasodilator Drugs Market Share by Country (2021-2026) Table 211. Middle East and Africa Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Middle East and Africa Peripheral Vasodilator Drugs Market Share Forecast by Country (2027-2032) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Peripheral Vasodilator Drugs Distributors List Table 216. Peripheral Vasodilator Drugs Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Peripheral Vasodilator Drugs Image Figure 2. Global Peripheral Vasodilator Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peripheral Vasodilator Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Peripheral Vasodilator Drugs Sales (2021-2032) & (k units) Figure 5. Alpha-adrenergic Blockers Image Figure 6. Global Alpha-adrenergic Blockers Sales YoY Growth (2021-2032) & (k units) Figure 7. Calcium Channel Blockers Image Figure 8. Global Calcium Channel Blockers Sales YoY Growth (2021-2032) & (k units) Figure 9. Potassium Channel Activators Image Figure 10. Global Potassium Channel Activators Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Peripheral Vasodilator Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Peripheral Vasodilator Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Peripheral Vasodilator Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Peripheral Vasodilator Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Peripheral Vasodilator Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Peripheral Vasodilator Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Peripheral Vasodilator Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Peripheral Vasodilator Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Peripheral Vasodilator Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Peripheral Vasodilator Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Peripheral Vasodilator Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Peripheral Vasodilator Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Peripheral Vasodilator Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Peripheral Vasodilator Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Peripheral Vasodilator Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Peripheral Vasodilator Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Peripheral Vasodilator Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Peripheral Vasodilator Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Peripheral Vasodilator Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Peripheral Vasodilator Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Peripheral Vasodilator Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Peripheral Vasodilator Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Peripheral Vasodilator Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Peripheral Vasodilator Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Peripheral Vasodilator Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Peripheral Vasodilator Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Peripheral Vasodilator Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Peripheral Vasodilator Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Peripheral Vasodilator Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Peripheral Vasodilator Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Peripheral Vasodilator Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Peripheral Vasodilator Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Peripheral Vasodilator Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Peripheral Vasodilator Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Peripheral Vasodilator Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Peripheral Vasodilator Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Peripheral Vasodilator Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Peripheral Vasodilator Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Peripheral Vasodilator Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Peripheral Vasodilator Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Peripheral Vasodilator Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Peripheral Vasodilator Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Peripheral Vasodilator Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Peripheral Vasodilator Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Peripheral Vasodilator Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Peripheral Vasodilator Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Peripheral Vasodilator Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Alpha-adrenergic Blockers
  • Calcium Channel Blockers
  • Potassium Channel Activators
  • Others
Applications
  • Hospital
  • Retail Pharmacies
  • Others
Companies covered
  • Endovastec
  • Aotecar Medical-B
  • Tibet Cheezheng Tibetan Medicine Co., Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Novartis AG
  • Pfizer, Inc.
  • GSK plc
  • Bayer AG
  • Bat Medical
  • AstraZeneca
  • Viatris, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Lupin
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peripheral Vasodilator Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Peripheral Vasodilator Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Peripheral Vasodilator Drugs Market by Type
  6. 1.3.1 Alpha-adrenergic Blockers
  7. 1.3.2 Calcium Channel Blockers
  8. 1.3.3 Potassium Channel Activators
  9. 1.3.4 Others
  10. 1.4 Global Peripheral Vasodilator Drugs Market Size by Type
  11. 1.4.1 Global Peripheral Vasodilator Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Peripheral Vasodilator Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Peripheral Vasodilator Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Peripheral Vasodilator Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Peripheral Vasodilator Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Peripheral Vasodilator Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Peripheral Vasodilator Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Peripheral Vasodilator Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Peripheral Vasodilator Drugs Industry Trends
  2. 2.2 Peripheral Vasodilator Drugs Industry Drivers
  3. 2.3 Peripheral Vasodilator Drugs Industry Opportunities and Challenges
  4. 2.4 Peripheral Vasodilator Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Peripheral Vasodilator Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Peripheral Vasodilator Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Peripheral Vasodilator Drugs Price (2021-2026)
  4. 3.4 Global Peripheral Vasodilator Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Peripheral Vasodilator Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Peripheral Vasodilator Drugs Company, Product Type & Application
  7. 3.7 Global Peripheral Vasodilator Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Peripheral Vasodilator Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Peripheral Vasodilator Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Peripheral Vasodilator Drugs Tier 1, Tier 2, and Tier 3
4 Peripheral Vasodilator Drugs Regional Status and Outlook
  1. 4.1 Global Peripheral Vasodilator Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Peripheral Vasodilator Drugs Historic Market Size by Region
  3. 4.2.1 Global Peripheral Vasodilator Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Peripheral Vasodilator Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Peripheral Vasodilator Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Peripheral Vasodilator Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Peripheral Vasodilator Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Peripheral Vasodilator Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Peripheral Vasodilator Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Peripheral Vasodilator Drugs by Application
  1. 5.1 Peripheral Vasodilator Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Others
  5. 5.2 Global Peripheral Vasodilator Drugs Market Size by Application
  6. 5.2.1 Global Peripheral Vasodilator Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Peripheral Vasodilator Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Peripheral Vasodilator Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Peripheral Vasodilator Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Peripheral Vasodilator Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Peripheral Vasodilator Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Peripheral Vasodilator Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Peripheral Vasodilator Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Endovastec
  2. 6.1.1 Endovastec Company Information
  3. 6.1.2 Endovastec Business Overview
  4. 6.1.3 Endovastec Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Endovastec Peripheral Vasodilator Drugs Product Portfolio
  6. 6.1.5 Endovastec Recent Developments
  7. 6.2 Aotecar Medical-B
  8. 6.2.1 Aotecar Medical-B Company Information
  9. 6.2.2 Aotecar Medical-B Business Overview
  10. 6.2.3 Aotecar Medical-B Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aotecar Medical-B Peripheral Vasodilator Drugs Product Portfolio
  12. 6.2.5 Aotecar Medical-B Recent Developments
  13. 6.3 Tibet Cheezheng Tibetan Medicine Co., Ltd
  14. 6.3.1 Tibet Cheezheng Tibetan Medicine Co., Ltd Company Information
  15. 6.3.2 Tibet Cheezheng Tibetan Medicine Co., Ltd Business Overview
  16. 6.3.3 Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Product Portfolio
  18. 6.3.5 Tibet Cheezheng Tibetan Medicine Co., Ltd Recent Developments
  19. 6.4 Teva Pharmaceutical Industries Ltd.
  20. 6.4.1 Teva Pharmaceutical Industries Ltd. Company Information
  21. 6.4.2 Teva Pharmaceutical Industries Ltd. Business Overview
  22. 6.4.3 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Portfolio
  24. 6.4.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Peripheral Vasodilator Drugs Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis AG Peripheral Vasodilator Drugs Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
  37. 6.7 Pfizer, Inc.
  38. 6.7.1 Pfizer, Inc. Company Information
  39. 6.7.2 Pfizer, Inc. Business Overview
  40. 6.7.3 Pfizer, Inc. Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer, Inc. Peripheral Vasodilator Drugs Product Portfolio
  42. 6.7.5 Pfizer, Inc. Recent Developments
  43. 6.8 GSK plc
  44. 6.8.1 GSK plc Company Information
  45. 6.8.2 GSK plc Business Overview
  46. 6.8.3 GSK plc Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK plc Peripheral Vasodilator Drugs Product Portfolio
  48. 6.8.5 GSK plc Recent Developments
  49. 6.9 Bayer AG
  50. 6.9.1 Bayer AG Company Information
  51. 6.9.2 Bayer AG Business Overview
  52. 6.9.3 Bayer AG Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bayer AG Peripheral Vasodilator Drugs Product Portfolio
  54. 6.9.5 Bayer AG Recent Developments
  55. 6.10 Bat Medical
  56. 6.10.1 Bat Medical Company Information
  57. 6.10.2 Bat Medical Business Overview
  58. 6.10.3 Bat Medical Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bat Medical Peripheral Vasodilator Drugs Product Portfolio
  60. 6.10.5 Bat Medical Recent Developments
  61. 6.11 AstraZeneca
  62. 6.11.1 AstraZeneca Company Information
  63. 6.11.2 AstraZeneca Business Overview
  64. 6.11.3 AstraZeneca Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 AstraZeneca Peripheral Vasodilator Drugs Product Portfolio
  66. 6.11.5 AstraZeneca Recent Developments
  67. 6.12 Viatris, Inc.
  68. 6.12.1 Viatris, Inc. Company Information
  69. 6.12.2 Viatris, Inc. Business Overview
  70. 6.12.3 Viatris, Inc. Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Viatris, Inc. Peripheral Vasodilator Drugs Product Portfolio
  72. 6.12.5 Viatris, Inc. Recent Developments
  73. 6.13 Sun Pharmaceutical Industries Ltd.
  74. 6.13.1 Sun Pharmaceutical Industries Ltd. Company Information
  75. 6.13.2 Sun Pharmaceutical Industries Ltd. Business Overview
  76. 6.13.3 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Portfolio
  78. 6.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  79. 6.14 Merck & Co., Inc.
  80. 6.14.1 Merck & Co., Inc. Company Information
  81. 6.14.2 Merck & Co., Inc. Business Overview
  82. 6.14.3 Merck & Co., Inc. Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Merck & Co., Inc. Peripheral Vasodilator Drugs Product Portfolio
  84. 6.14.5 Merck & Co., Inc. Recent Developments
  85. 6.15 Lupin
  86. 6.15.1 Lupin Company Information
  87. 6.15.2 Lupin Business Overview
  88. 6.15.3 Lupin Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Lupin Peripheral Vasodilator Drugs Product Portfolio
  90. 6.15.5 Lupin Recent Developments
  91. 6.16 Bristol-Myers Squibb Company
  92. 6.16.1 Bristol-Myers Squibb Company Company Information
  93. 6.16.2 Bristol-Myers Squibb Company Business Overview
  94. 6.16.3 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product Portfolio
  96. 6.16.5 Bristol-Myers Squibb Company Recent Developments
  97. 6.17 Boehringer Ingelheim International GmbH
  98. 6.17.1 Boehringer Ingelheim International GmbH Company Information
  99. 6.17.2 Boehringer Ingelheim International GmbH Business Overview
  100. 6.17.3 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product Portfolio
  102. 6.17.5 Boehringer Ingelheim International GmbH Recent Developments
  103. 6.18 Abbott Laboratories
  104. 6.18.1 Abbott Laboratories Company Information
  105. 6.18.2 Abbott Laboratories Business Overview
  106. 6.18.3 Abbott Laboratories Peripheral Vasodilator Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Abbott Laboratories Peripheral Vasodilator Drugs Product Portfolio
  108. 6.18.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Peripheral Vasodilator Drugs Sales by Country
  2. 7.1.1 North America Peripheral Vasodilator Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Peripheral Vasodilator Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Peripheral Vasodilator Drugs Market Size by Country
  6. 7.2.1 North America Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Peripheral Vasodilator Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Peripheral Vasodilator Drugs Sales by Country
  2. 8.1.1 Europe Peripheral Vasodilator Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Peripheral Vasodilator Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Peripheral Vasodilator Drugs Market Size by Country
  6. 8.2.1 Europe Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Peripheral Vasodilator Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Peripheral Vasodilator Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Peripheral Vasodilator Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Peripheral Vasodilator Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Peripheral Vasodilator Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Peripheral Vasodilator Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Peripheral Vasodilator Drugs Sales by Country
  2. 10.1.1 South America Peripheral Vasodilator Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Peripheral Vasodilator Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Peripheral Vasodilator Drugs Market Size by Country
  6. 10.2.1 South America Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Peripheral Vasodilator Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Peripheral Vasodilator Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Peripheral Vasodilator Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Peripheral Vasodilator Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Peripheral Vasodilator Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Peripheral Vasodilator Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Peripheral Vasodilator Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Peripheral Vasodilator Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Peripheral Vasodilator Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Peripheral Vasodilator Drugs Value Chain Analysis
  2. 12.1.1 Peripheral Vasodilator Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Peripheral Vasodilator Drugs Production Mode & Process
  7. 12.2 Peripheral Vasodilator Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Peripheral Vasodilator Drugs Distributors
  10. 12.2.3 Peripheral Vasodilator Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst